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INTRODUCTION 
In the course of studies on the formation of 2,3-DPG* 
by erythrocyte preparations incubated ,.,i th nucleosides, such 
as inosine, and orthophosphate, it was necessary to measure 
2,3-DPG concentrations enzymatically11 • In some of these 
samples, the enzymatic assay gave no evidence of any 2,3-DPG 
even. though substantial amounts of this compound could be 
isolated from the incubation mixtures by column chroma-
tography. The samples in which difficulty was encountered 
were those in which relatively high concentrations of ino-
sine had been employed as the substrate. This suggested 
that the inosine was interfering with the enzymatic assay. 
2,3-DPG was measured by its ability to catalyze the 
phosphoglyceromutase reaction in the coupled assay of Towne, 
Rodwell, and Grisolia51 shoWl~ in Figure l. The PEP was 
measured by its optical absorption at 240 mu. 
Figure 1. Reaction Sequence of 2,3-DPG Assay. 
2,3-DPG 
3-PGA 2-PGA 
phosphoglycero-
mutase 
enolase 
*The abbreviations used are: Pi, inorganic phosphate; 2,3-
DPG, 2,3-diphosphoglycerate; 2- or 3-PGA, 2- or 3-phospho-
glycerate; PEP, phosphoenolpyruvate; II~, inosine-5-phos-
phate; AMP, ADP, and ATF, adenosine mono-, di-, and tri-
phosphate; respectively; RBC, red blood cell; Tris, tris-
(hydroxymethyl)aminomethane; and, Hct,, hematocrit •. 
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Further studies on the various components of the 2,3-
DPG assay indicated that inosine was interfering with the 
assay by apparently inhibiting enolase. The purpose of 
this investigation was to study this effect of inosine, and 
also other purine and pyrimidine derivatives, on enolase 
activity. 
Our interest in this effect of purine derivatives on 
enolase activity was increased by its possible impact on 
the interpretation of metabolic studies on erythrocytes in 
which nucleoaides were employed as substrates. Use of 
nucleosides, rather than glucose, as a sugar source in RBC 
preparations has become common in the past decade because 
of the ability of nucleosides, particularly adenosine and 
inosine, to prolong considerably the viability of stored 
erythrocytes47 • A nucleoside phosphorylase at the cell 
surface is able to split inosine causing the liberation of 
ribose-1-phosphate which then can be further metabolized by 
the cell through the pentose-phosphate pathway7 ,35 • 
Ribose alone can not be metabolized by the cell since 
the erythrocyte does not have a ribose kinase to carry out 
the initial phosphorylation of the pentose. Phosphorolysis 
of nucleosides presents a means '\'Thereby the phosphate ester, 
ribose-1-phosphate can enter the cell. No cell energy is 
required for this process. These reactions are able to 
revive cells after prolonged storage, when their ATP content 
3 
is too low to promote the initial phosphorylation of 
glucose22,43,47. 
The physiolozical significance of an ir.hibition of 
.. 
eno~ase by purine derivatives, if it did indeed occur, 
would be considerable. Prankerd47, Mills and Summers39, 
and others have deiJonstrated that add.i tion or· inosine and 
adenosine to blood which has been depleted of 2,3-DPG by 
storage or prolonged incubation leaas to rapid restoration 
of the 2,3-DPG level. This rather specific effect has been 
attributed to the fact that nucleosides bring in Pi in 
addition to the pentose. It has been further sus3ested that 
the availability of pentoses ratl:er than glucose as a carbon 
source hli0l1. t reduce the requirement for ATP, since pe::.:-c..oses 
partially siciestep one of the ATP requiring steps in gly-
colysis. The adG.i tional Pi made avr.il;;;.ble to the cell might 
then be stored as 2, 3-DPG in circuls.tinc; :"lurnan erythrocytes 47 ' 
(J.H. Foster, personal communication). Now, the fact that 
the nucleosides rr..ay )roduce a ;J.e"c..abolic block at the enolase 
level must be also considered in relation to its effect on 
increasing 2,3-.DPG synthesis in the human RBC. 
Inosine and various other purine and pyrimidine deriva-
tives are normally found in the RBC, but in lot'l concentra-
tions. On the other hand, the adenine derivatives in the 
norrnal erythrocyte approach a total concentration of 
I 38 1 umole ml • This is within the concentration range which 
appeared to interfere with the enolase assay. Therefore, 
nucleosides might also participate in a control mechanism 
for erythrocyte glycolysis. 
HISTORY 
Enolase which catalyzes the glycolytic dehydration 
reaction shown in Figure 2 was first discovered by Lohmann 
Figure 2. Dehy~ration of 2-PGA. 
coe-
r -2 
CH-OP03 
I 
CH20H 
2-:PGA 
coo-
l 
-2 
C-OP03 + H20 II 
CH2 
PEP 
20 
and Meyerhof in 1934 while studying the formation of 
5-
pyruvate from 3-PGA by muscle extracts. As would be expected 
of an enzyme which mediates an essential reaction in glycoly-
sis, enolase has since been found to exist in all metabol-
2,18,52 21 ically active cells investigated , including RBC's • 
However, little information is available on RBC enolase 
other than the rate of formation of lactic acid from glucose 
by intact erythrocytes47 , which indicates the presence of 
enolase, and results from enzymatic assays of blood hemoly• 
sates for enolase activityl,6, 21 • 
Enolase has been crystallized from yeast53, rabbit 
muscle10, and potatoes2, but only the yeast enzyme has been 
studied in detail. It has been of considerable interest 
because it is a good example of a metal-ion-activated enzyme. 
The reader is referred to an excellent recent review by 
Malmstrom32 for an extensive discussion of the properties 
6 
of this enzyme. Only tho~e properties which are pertinent 
to this investigation will be treated here. 
Crystalline enolase has been shown to be generally 
homogeneous from the collected results of studies based on 
44 31 . 24 
chemical analysis ' , ultracentrlfugation , and electro-
phoresis29. The constant specific activity of enolase upon 
repeated crystallization also testifies to its purity32. 
The conditions of comparable enolase assays, however, must 
be followed in detail; for, enolase activity is extremely 
sensitive to changes in the assay medium, particularly to 
small traces of metals (lo-7 M) which can cause large 
changes in activity. Therefore, a metal chelator, such as 
glycine or ethylenediaminetetraacetate (EDTA), is included 
in the assay medium to remove these metals and stabilize 
the enzyme activity. The specific activity of the enzyme 
can be detennined by use of the initial velocity of the 
reaction57 • 
The molecular wei&ht of enolase has been determined 
by a variety of methods including those based on Hg analysis 
(1 atom Hg/mole of enzyme) 4 , sulfide analysis (8 S/mole)53, 
29 
sedimentation and diffusion studies , and light scattering 
techniques4 ; all giving a molecular weight close to 67,000. 
Enolase has the absorption spectrum of a simple protein53 
indicating the absence of a prosthetic group. It is thought 
to be a single peptide chain32 containing approximately 
647.2 amino acid residues31 • The amino acid content accounts 
7 
for the molecular weight of the protein, and the sulfide 
concentration of the protein is equivalent to the methionine 
content alone31, confirming the absence of cysteine or 
cystine groups. 
As might be inferred from the techniques used in its 
purification, the enzyme retains activity under a wide 
range of conditions. Degradation studies44 show that ap-
proximately 150 residues may be removed from either end of 
the molecule without the enzyme loosing its catalytic prop-
erties, which suggests a central position for the active. 
site of the enzyme. Further investigation along this line 
using radioactive Hg31 has opened the way to a possible 
direct chemical identification of the metal binding site 
with the Hg-enolase. 
Some information of the chemical nature of the active 
site is available. Tests showing the effect of specific 
reactive groups on the activity of the enzyme have led to 
the knowledge of possible groups within the active site. 
For example, the use of -SH reagents with yeast enolase 
shows no inhibition57 (potato enolase does) 2 emphasizing 
the laci~ of a free -SH group at the active site of the 
enzyme. Addition of bromoaceta te to yee.s t enolase leads to 
inactivation of the enzyme3. Detailed studies showed that 
the inactivation is due to the carboxylation of one or more 
methionine residues. Since Mg~~ and 2-PGA together, but 
8 
not alone, will protect tne protein from inactivation by 
bromoacetate, it can be deduced that methionine is involved 
with the active site of the enzyme. 
Much evidence has been obtained indicating also the 
existence of an imidazole group(s) at the active site. 
Wold and Ballou57 have found that photooxidation, considered 
specific for imidazole groups, causes a complete loss of 
enolase activity, but fomaldehyde, believed to act mainly 
on~-amino groups had a much smaller effect. Studies on 
the effect of pH on enolase activity57 indicate that a group 
with a pK of 7.5 is present at the active site. This could 
be an GO -amino, an -SH, or an imidazole group; however, 
earlier-mentioned evidence eliminates the first two possi-
bilities. 
53 The early studies of Warburg and Christian on the 
now well-known iru~ibitory effect of F- on enolase activity 
might be mentioned here. The mechanism of this F- inhibi-
tion is by the removal of the enzyme activating-ion through 
the formation of Mg~fluorophosphate*, only confirming the 
need of a metal ion for activity. The inhibition not only 
has a direct dependence on the Mg++ concentration but also 
is dependent on the presence of orthophosphate**· The F-
illi1ibition is competitive and, therefore, may be reversed 
by the addition of J.vlg••. 
*See Figure 3, p. 9. 
**See Table 1, p. 10. 
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Table 1. T~e Dependence or53- Inhibition of Enolase on Mg~and P04 Concentrations •• 
F.., Mt++ 
0.5 X 10..;:3 M 2.7 X lo-3 M 
1.0 X 10-3 M II 
1.5 X lo-3 M 11 
" 2.7 :X: 10-
4 M 
1.7 X 10-3 M 2.7 X 10-3 M 
tl 
" 
Table 2. Substrate Analogs57. 
Compound 
D-lactic acid 
D- glyceraldehyde 3-phosphate 
dihydroxyacetone phosphate 
&-glycerol phosphate 
~-hydroxypropionic acid 
phosphate 
D-lactic acid phosphate 
D-glyceric acid 3-phosphate 
D-erythro-2,3-dihydroxy-
butyric acid 2-phosphate 
D-erythro-2,3-dihydroxy-
butyric acid 3-phosphate 
.inorganic phosphate 
P0-3 4 
2.5 X lo-3 M 
tt 
tl 
II 
0.5 :X: 10-3 
10-3 
M 
1.0 X M 
Inhibition 
None 
tt 
II 
tl 
Competitive 
II 
tt 
It 
tl 
Non-competitive 
% Inhibition 
45.0 
71.6 
78.4 
27.5 
53.4 
70.8 
Ki (mole/1) 
4 5 10-4 • X 
3.5 X 10-44 
4 5 10-
6:o ~ 10-4 
3.3 X 10-3 
-3 6.4 X 10 
11 
The metal-binding properties of this metal-requiring 
· " 24-34,et.al. · 
enzyme studied primarily by Malmstrom are not 
only important in consideration of the mechanism of the 
catalytic reactio~ as will be pointed out later in this 
discussion, but have added also to the evidence for the 
28 involvement of an imidazole group and of a probable car-
boxy group at the active site3 • Moreover, from his obser-
vation that Be•~ seems to interact less strongly than Mg++ 
and ca•+ at the active site of the enzyme, Malmstrom thinks 
that the possibility of involvement of phenolic-OR group 
may be excluded26 • 
Studies on the mechanism of the enolase reaction 
have been facilitated by the high absorption of PEP at 
240 mu compared to the negligible absorption by 2-PGA, as 
a result of the formation of the double bond of PEP in the 
dehydration reaction33 • The velocity of the ree.ction thus 
may be accurately measured spectrophotometrically53, rather 
I 
than by measuring acid-l.abile phosphorus formation as -v:as 
done in earlier work. Initial velocities, contrary to 
early reports by Warburg and Christian53, may be used for 
the determination of rate equations3 ,57 . Once again, the 
need to know the assay conditions in detail is emphasized 
in order to obtain accurate activity measurements; for, the 
absorption of PEP is known to vary greatly with pH and ion 
concentration due to the binding of protons and other 
cations56 • 
12 
The equilibrium ~onstant also depends on the assay 
medium, particularly the pH, the metal ion concentration, 
and the ionic strength. Values have been reported rang-
ing from 1.9 - 6.3. The most detailed work by Wold and 
Ballou56 gives 6.3 as the true constant. 
Wold and Ballou56 ,57 also tested series of substrate 
analogs for substrate activity and found 2-PGA and PEP to 
be the only s~bstrates for enolase. Some of the analogs 
were found to be inhibitors*. From this work, Wold and 
Ballou concluded that competitive inhibitors of 2-PGA 
must have both a carboxyl and a phosphate group. 
The kinetics of the enolase reaction are·involved 
for several reasons. First, the substrate inhibits at 
high concentrations. Various explanations have been given 
for this phenomenon. Rather than due to rellloval of the 
activating ion through complex formation with the substrate 
54 ... 2 
as has been suggested by others '~ , Wold and Ballou57 
think that the inhibition is due to a combination of the 
substrate with a neighboring site on the enzyme, namely 
the point at which Mg-1-f is thought to bind with the enzyme. 
Ho,.rever, Westhead and Malmstrom54 showed that in 0.50 !vi 
KCl (i.e. at high ionic strength) the substrate inhi"'oi-
tion is eliminated. This suggests the,t the inhibition is 
related to increase in ionic strength by the added 2-PGA. 
Also with high ionic strengths of KCl, valid pH data 
*See Table 2, p. 10. 
13 
may be obtained for the e~olase reaction57. A pK of 7.5 is 
found for the active site. Inactivation occurs at extremes 
of pH which emphasizes that only fully dissociated substrates 
can participate in the reaction. This inactivation is 
reversible. 
The effect of temperature on the Hg••-enolase activity 
in non-phosphate buffers is found to follow the law set 
54 forth by the Arrhenius equation *· It had been reported 
earlier27 that at low temperatures in phosphate buffers 
enolase activity veered from its nonnal. However, this 
abnormality was found to be caused by a non-competitive 
i lib·+· b p 57 nn ~u~on y i • 
Detailed work on the kinetics of the metal-ion acti-
vation may be found in publications of Malmstrom24-34 ,et.al: 
Basically, the metal ion has a function equivalent to a co-
enzyme of enolase. Various divalent metals may act as acti-
vators, l·!g•• being the most effective57 ' 26 • However, I•!g++ at 
high concentrations also inhibits the enolase activity57**· 
It has been suggested tlw.t the mechanism of Hg""+ inhibition 
is similar to the inhibition by 2-PGA54 ,57. That is, the 
excess l•IgH is competing for the substrate position at the 
active site as compe.re to excess substrate competine; for 
the Mg.., site with substrate inhibition. pH studies have 
suggested the involvement of an imidazole sroup also with 
*See Table 3, p. 13. 
**See Figure 4, p. 14. 
13a. 
Table 3. Properties o~ Hg••Enolase ~rom Yeast. 
Property Value Re~erence 
1. molecular weight 
2. chemical analysis 
67,000 
53.62% c 
7.55% H 
17.34% N 
.38% s 
no P 
(32) 
(32) 
3. N-terminal amino acids ala-gly-(val,1ys) (32) 
C-termin~l ~ino acid leu-
4. speci;fic activity (see 120,00 OD/mg/min (32) 
Table 7, #1, for as say · 
conditions) 
5. turnover number (moles 5,400 
2-PGA.used/mole enzyme/ 
min.) 
(32) 
7. KM 
= (PEP) (2-PGA) 
8 AFO 
• .. 298 
9. s2o 
10. A (in Tris buffer) 
11. substrates 
12. optimum (Mg ..... ) 
13. pH optimum 
1.9 - 6.3 
1.5 X 10-4 M 
-1090 cal/mole 
(32) 
(37) 
(56) 
5.8 s (32) 
14,270 cal/mole/deg. (32) 
2-PGA and PEP (57) 
ca. 2 umoles/ml (57) 
7.5 (57) 
.200 
.160 
.080 
.040 
.000 
-- ... 
,/'' ' 
/ ' I \ 
/ \ 
/ \ 
/ \ 
' 
' 
' 
1 2 3 4 
.PM9++ 
FIGtJIQ 41 llq ++ Ae,'XVA'l'IOlf OP BllOLASE 
• cry•talline rabbit .u•cle 
enol•••· 1.6 B!U! 
• partially purified Brew.r'• 
,__t enola-, l. 4 B. u. 
1*1++ - ~ loq (Mg++) 
14 
: ..... 
1s 
the metal-binding si~e3similar to the one at the substrate-
binding site. This evidence strengthens the possible expla-
nation of the co!Ilpeti tion between :Mg++ and 2-PGA. 
The mechanism of the enolase reaction is still unre-
solved. However, a few definite facts about the enzyme are 
available. From these, several reasonable mechanisms for 
the reaction have been postulated. The enzyme, the ionized 
substrate, and the metal ion are thought to be involved in 
a ternary complex. Substrates or competitive irillibitors 
must have a fully ionized phosphate and carboxyl group close 
together. The enzyme-Mg•• complex is the true catalytic 
species. Direct binding determinations suggest a possible 
26 bridging function for the metal ,. mediating the binding of 
2-PGA to the protein. Therefore, the reaction is thought 
to occur in the following order: 
Enzyme + Mg++ ...,,._...,,. Enzyme-Mg++ 
/ l-!g•• 
-+ Substrate-3 ~---•• Enzyme 3 
'Substrate-
The exact tertiary structure of this complex is still not 
known. The active site is now thought possibly to include 
two imidazole groups and one or more methionine groups. To 
explain the possible importance of the methylated sulfhydryl 
groups, Brake and Wold suggested the reaction illustrated 
by Figure s3 • 
16 
Figure 5. Hy)othetical Role of the Methylated Sulf-
hydryl Groups in Enolase. 
R 
I 
S + HO-CH2-CH2-Rl I 
R 
R 
J 
heat 
S +- H2 C - CH - R t 
Rl 
Malmstrom's hypothesis suggests that the importence 
of the t1-·10 imidazole groups is to act as 9roton donor and 
acceptor, as depicted in Figure 6. About this hypothetical 
Figure 6. Hypothetical Reaction Mechanism for an 
Enzymic Dehydration. 
I 
X----R 
.. 
reaction mechanisLl for enolase 1-ialmstrom states in a review 
33 
of hydration and deh;ydration reactions : 
11 In the case of the other hydrases, the ideas con-
cerning mechanism are derived mainly from concepts 
developed in vrork on ful:):).arase and enolase. In 
both these enzymes, two imidazole groups, one 
charged and one uncharged, are believed to be 
present in the active center. These groups act 
as proton donor and acceptor (as seen in Figure 6) 
which gives a schematic representation of the 
molecular events at the active center of the 
enzyme. This mechanism requires a polarization 
in the substrate, ~a indicated in the figure. 
As shown by Stearn , such an effect could be 
induced by a dipole in the catalyst, so that the 
proton donor and acceptor could be responsible 
also for the polarization of the substrate. How-
ever, in the case of imidazole groups, where the 
proton acceptor is uncharged, this does not seem 
·possible. Instead, the polarization must be 
thought to be induced via the interactions X ••• R 
and R' ••• Y. The substrate binding groups X and 
Y, which would also include cofactors, such as 
Mg in enolase, would then depend on the nature 
of the substrate, whereas the reactive groups 
would be the same in all the enzymes. Although 
a generalized mechanism of this sort ap~ears to 
be consistent \vi th present information on hydra-
tion-dehydration enzymes, its sketchy nature in-
dicates that much fundamental work remains to be 
done before we understand the molecular basis of 
their catalytic action." 
Although neither of the two above hypotheses have 
17 
thorough experimental evidence behind them, a combination 
of the two might eventually be found to explain the true 
mechanism of the enolase reaction. 
18 
EXPERI~mNT.~ AND DISCUSSION 
Materials 
Crystalline rabbit muscle enolase, purine and pyrim-
1dine derivatives, 2-PGA,3-PGA, and 2,3-DPG y.;ere obtained 
from California Corporation for Biochemical Researc11. The 
phosphoglycerates, which were obtained as the bari~~ salts, 
were converted to the acid form by ion-exchange with Dowex-
SO(H•). All solutions were brought to pH 7.4 i.vith NaOH. 
Phosphoglyceromutase was partially purified from 
brewer's yeas~ acc·::>rciins to the method of Tovrne, Rodvrell, 
and Grisolia49. Brew·er' s: yea2t e~1olase wc.:,s purified ac-
cording to the method of Warburg and Christian53 through 
two acetone and two ethanol fractionations only. It was 
stored in 50% (1TH4) 2S04· Phosphoglyceromutase activity '\'ras 
negligible. 35% of the activity remained after storase 
for seven months. 
Effect of Inosine on the Enolase Assay System 
The first series of experiments \'i8.::: designed to 
examine in detail the effect of inosine on enolase activity. 
These studies used the following assay method of E. Racker4t-
which is specific f'or eaolase activity: 
*Assay furnished by F.J. Lionetti, Ph.D., Boston Univ., 
Biochemistry Dept. 
ml 
.05 
.03 
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1 Iv1 Tris, pH 7.4 
lO~;b Glycine 
.05 M ~fgCl2 
.10 lJl 2-PGA 
enolase 
.05 (unless otherwise noted) 
• 03 ( II It It ) 
The rate of formation of PEP was follo'\'red spectrophoto-
metrically* at 240 mu. 
Inosine concentrations customarily used for incuba-
tion with erythrocyte preparations, i.e. 5-10 umoles/ml, 
had been found previously to ir~ibit enolase activity com-
pletely when assayed by the above nethod. Detailed studie.s 
of the inhibition of the activity of both crystallized 
rabbit muscle and partially purified yeast enolase revealed 
that inhibition occurred at inosine concentrations as low 
as 0. 25-0.75 urnoles/ml, as shown in Figure 7**. 50/b inhi bi-
tion was obtained at 0.3-0.4 umoles. of inosine/ml. 
The relative strength of this apparent inhibition 
phenomenon is realized when the ratio of inhibitor to sub-
strate is calculP.ted; i.e. approximately 1:10 at 50% inhi-
bition. Therefore, inosine appeared effective as an inhib-
itor at concentrations approximately ten times less than 
the substrate concentration. Whereas, F- inhibition, based 
on the substrate and ¥~t~ concentrations of the above assay 
would have only a ratio of approximately 1:2. A comparison 
of the F- to the inosine inhibition at this point, however, 
*All 1pectrophotometric studies done with a Carl Zeiss 
PMQ II spectrophotometer. 
**See Figure 7, p. 20. 
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appeared unreasonable since the two inhibition curves bore 
no resemblance*. 
Since the partially purified yeast enolase showed 
the same ir~ibition phenomenon as the crystalline enolase, 
and was available in large quantities, it was used for all 
future assays requiring addition of enolase, unless other-
wise specified. 
Inasmuch e"s the inhibition of enolase 'tl~;.s first ob-
served in the course of experiments on erythrocytes, it was 
important to know whether blood enolase wo..s also i~1.hi bi ted 
by inosine. The isolation of blood enolase is complicated 
by the high herr::.oglobin concentration. However, it was pos-
sible to remove most of the hemoglobin by adsorption on 
diet~1ylarninoethylcellulose (DEAE)l5,16,40,50, Fresh~ washed 
erythrocytes \'!ere hemolyzed in 0. 005 l~ phosph3.te buffer, 
pH 7.4, and added to 9 gm. DEAE, pH 7.5. The DEAE-hemoly-
sate was centrifuged. The superna.tan t vras treated vli th two 
acetone fractionations accordins to the purification method 
of \v"arburg and Christian, and stored in 50/b (NH4 )2so4 • The 
results of in..lJ.ibi tion studies i"ii th the partially purified 
blood enolase are included in Figure 7**· Inosine had the 
same effect on blood enolase as on rab~it muscle and yeast 
enolase. 
*See Figures 3 & 7, pp. 9 & 20, respectively. 
**See Figure 7, p. 20. 
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Comparison of the Effect of Other Purine 
and Pyrimidine Derivatives 
The inosine inhibition phenomenon brousht up the 
question of vlhether other purine and pyrimidine derivatives 
would also have the capacity to inhibit enolase activity 
as measured spectrophotometrically. Consequently, the 
compounds listed in Table 4* vvere tested under sj_milar 
conditions as inosine. Concentrations of these com)ounds 
were measured using the extinction coefficients included in 
the table. 
The base and monophosphate of inosine (hypoxanthine 
and HIP, respectively) showed inhibition of enolase identi-
cal to inosine-r.4 *. Ribose alone in conc~mtrations up to 
7.5 umoles/ml showed no iru1ibition at all. Therefore, it 
appeared that :L t was the base :iJOiety which v;as c~.nping the 
inhibition. 
As shown in Figure 9***, all the yurine and pyrimi-
dine derivatives tested produced inhi bi tj_on curves similar 
to inosine. However, the strength of inhibition vc.:>.ried 
with the compound. There was no apparent correlation be-
tween structure and degree of inhibi tion·li-***. Uric acid was 
the strongest inhibitor. Purines were not necessarily more 
*See Table 4, p. 23. 
**See Figure 8, p. 24. 
***See Figure;9, p. 25. 
**ii-*See Figure 10, p. 26. 
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Table 4. Extinction Coefficients of Purine and 
Pyrimidine Derivatives. 
Compound )\max ema.':: x 10-4 pH Reference 
adenine 260 1.42 7.0 (17) 
adenosine 260 1.51 7.0 (17 ~ 
AJ.fl? 260 1.58 7.0 (17 
ADP 260 (used 1.59) 7.0 
-
ATP 260 1.60 7.0 (17) 
cytidine 271 '19 .c 7.0 (48) 
guanosine 250 .80 7.2 (17) 
hypoxanthine 250 1.05 7.2 (17) 
inosine 250 1.18 7.2 (17) 
IMP 250 (used 1.13) 7.2 
uracil 259 .82 2.0 (48) 
" 259 .91 7.0 * uri dine 262 1.00 7.0 (17) 
uric acid 290 1.22 7.0 (17) 
xanthosine 263 .C95 2.0 (48) 
II 270 .716 7.0 
'* 
*Experimental. 
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effective thru~ pyrimidines; for although inosine was strong-
er than uridine, cytidine was stronger than adenosine. 
Also, no relation was found between the degree of inhibi-
-N ~ -NH, . 
tion and the -C,...C-NH~ or -c, c=o structure; for inosine 
... ' ..... ' 
was stronger than adenosine but adenosine is stronger than 
uridine, etc. There was also no correlation between solu-
bili ty of the con:pounds* and degree of in ... 'l.i bi tion. 
Adenine, adenosine, A}~, ADP, and ATP, all had equal 
inhibition strength, indicating again that it was the base 
which was inhibitory. 
At concentrations below i~~ibitory levels, there 
again appeared to be an initial stimulation as with ino-
sine. No explanation could be given for this o;:;servation. 
Inhibition by inosine and adenosine was found to be 
additive; hm-rever, F- and inosine inhibition lvere found to 
be only partially additive. 
Kinetic Measurements 
In attempts to uncover the mechanism of inhibition 
by inosine of enol~se activity as measured spectrophoto-
metrically, studies with varying substrate concentrations 
but a constant enzyme concentration were carried out at 
varying iru~ibitory concentrations of inosine. The results 
*See Table 5, p. 28. 
Table 5. Water Solubility of Purine and Pyrimidine 
Derivatives. 
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Compound Solubility 
(gm/100 ml H2o at 23°C) 
Reference 
adenine 
adenosine 
cystosine 
cytidine 
guanine 
guanosine 
hypoxanthine 
inosine 
uracil 
uri dine 
uric acid 
xanthine 
xanthosine 
.os 
soluble 
3.3 
very soluble 
almost insoluble 
.076 
.071 
1.6 
.358 
soluble 
very insoluble 
.0069 
sparingly soluble 
(48) 
(36) 
(48) (36) 
(36) (48) 
(48) (48) 
(48) 
(36) 
(36) 
(48) 
(36) 
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1-.rere graphed as Line'lveaver-Burlc ::;:>lots, i.e. 1/v • vs. 1/S, 
applying the method of the "least squares 11 9 to the col-
lected data. Since Hofstee14 has pointed out that 1/v• 
vs. 1/S plots overemphasize data obtained at low substrate 
concentrations, the velocity was also plotted against v•/s. 
This gives equal emphasis to data obtained at all substrate 
concentrations. 
As seen in Figures 11* and 12**, studies of this 
sort gave no definite evidence for either competive or 
non-competitive inhibition of enolase by inosine. One 
could not say that either Vmax or KM remained constant 
when inosine was added. No actual kinetic pattern ap-
peared to be followed at all. 
If the inhibition \"i'"ere com_;;eti ti ve, increasing the 
substrate concentration should relieve the inhibition 
effect, since the ini.1ibitor would be com)eting with the 
substrate for the same site on the enzyme. Neither ad-
dition of more substrate to the assay medium after the 
reaction had been going awhil~ nor increasing the initial 
substrate concentration .. changed .the inhibitory effect of 
inosine on enolase. These results suggested that the in-
hibition might be non-competitive. 
Increasing the enzyme concentration, now, should 
*See Figure 11, p. 30. 
**See Figure 12, p. 30. 
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effect non-competitive inhibition 1:5y increasing the con-
centration of inhibitor necessary to obtain a.given degree 
of inhibition. Enolase concentrations wer~,: th.erefor,,.:.i:a-
creased as much as two hundred times. Nevertheless, 0.25-
0.75 umoles of inosine/ml still showed the same strength 
of inhibition of enolase activity. 
Ir one plots v0/v0 I against inhibitor concentration, 
a straight line should result13 • In the case of enolase 
inhibition by inosine, a straight line was not obtained*. 
This suggested that an abnormal type of inhibition was 
taking place. 
It was possible that inosine was inhibiting enolase 
by removing the activating metal, Mg+~ from the medium by 
chelatio~ or some other means, in a manner similar to F-. 
However, an optimum Mg++ concentration (2.5 x 10-3 M) and 
a.n inhibitory concentration of Mg* (15 .0 x 10-3 M) gave 
inhibition curves (%Maximum Velocity vs. (I)) which were 
identical at both :rvrg++concentrations. Nor did addition of 
more Mg+t after the reaction had started~effeet.·1nos1ne,~s 
strength of inhibition. If Mg++and inosine were complexing, 
the lowest possible ratio would be that of 1:1. At 100% 
inhibition 0.75 umoles of inosine/ml is present. In the 
routine assay, 2.5 umoles of Mg+~ml was added. Therefore, 
2.5 umoles Mg"* added minus 0.75 umoles Mg++-Inosine complex 
*See Figure 13, p. 32. 
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would leave 1. 75 umoles of ffiee 11g+ /ml, which 1.vas still 
within the optimum Mg"'• range for enzyme activity. Thus, 
it appeared from the above experiments that the inhibition 
of enolase v.ras not due to a removal of Iv!g""+ by inosine. 
Since. the purine and pyrimidine ring structure bear 
some resemblance to the imidazole ring of the histidine, 
which has been postulated to be at the active site of 
enolase3~, histidine and imidazole were tested as possi-
ble inhibitors. They were both found to have no effect on 
enolase activity. Nor did they protect enolase from the 
inhibitory effect of inosine. 
Therefore, no definite mechanism of the enolase in-
hibition by inosine was suggested from the above data. The 
only conclusion was that the curves representing this inhi-
bition phenomenon were abnormal. 
Inosine Concentration within Erythrocyte Preparations 
Our interest in the apparent inhibition of enolase 
activity by inosine and other nucleic base deriv~tives was 
increased by their possible effect on the interpretation 
of metabolic studies on erythrocytes incubated in media 
containing inosine and adenosine. Consequently, it was 
important to know if inhibitory concentrations of inosine 
*See p. 15. 
were to be found inside the cells in such experiments. 
Inosine concentrations in deuleted* cell preparations, 
which are actively synthesizing DPG, vrere of particular 
interest. 
In studies l'ii th fresh, washed erythrocytes incu-
bated in media containing hypoxanthine Lassen and Over-
gaard-Hansen19 found that hypoxanthine does set into the 
erythrocyte in concentre.,tions equal to, or greater than, 
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that of the mediwn within two minutes as shown in Table 6. 
Table 6. Rate of Hypoxanthine Entrance into Ery-
throcyte Preparations. 
Time (minutes} 
2 
16 
52 
85 
umoles hyuoxanthine/ml 
of cell water 
A B 
3-:2 675 
3.3 6.0 
3.3 6.0 
3.9 6.4 
Hct. = 50% 
A = incubated in 2.6 umoles hypoxanthine/mi. 
B. II II 5.1 " " "· 
The next series of experiments was, therefore, set up to 
study concentrations of inosine and/or hypoxanthine with-
in depleted erythrocytes of preparations incubated with 
either inosine or hypoxanthine. 
To study depleted cells, fresh heparinized human 
blood was incubated in air with 200 mg% glucose for 24 
hours at 38°C with gentle shaking. The blood was then 
washed ~two times with 0.15 M NaCl and the white blood 
*Depleted erythrocytes are cells which have been depleted 
of 2,3-DPG by preincubatien with glucose for 24 hours39. 
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cells removed. The washed, depleted erythrocytes were 
incubated ln 50 ml flasks containing.a total sample vol-
ume of 20 ml. The samples included 10 ml cells (i.e. the 
final Hct. =50%); 0.10 :r-i phosphate buffer, pH 7.4; ino-
sine equal to 12.5, 5.0, or 2.5 umoles/ml or hypoxanthine 
equal to 5.0 or 1.5 umoles/ml; and, NaCl at concentrations 
which would make the total solution added to the blood 
isotonic. Two and four ml samples were taken from each 
flask at 50, 70, and 190 minutes. 
The 2 ml srun~les were placed in boiling water for 
15 minutes, and then, centrifuged. The supernatant was 
saved. The precipitated protein was washed once again 
and recentrifuged. The supernatant and washinss were com-
bined and diluted to 10 ml. These supernates were desig-
nated as Total. 
The 4 ml samples were centrifuged. One ml of medi-
um was removed and treated as above. These supernates 
were designated as Nedium. 
'rotal and Nedium filtrates v:ere assayed for inosine 
and/or hypoxanthine. The assayl7,37.depends on the reac-
tion sequence seen in Figure 14. Xanthine oxidase is 
Figure 14. Reaction Sequence of Inosine and Hypo-
xanthine Assay. 
Pi ribose-1-P 
inosine >- • 4 .- hypoxanthine ,. ~ -·~ uric acid 
nucleoside xant;.hine 
phosphorylase oxidase 
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first added. The amount of hypoxanthine present may then 
be calculated by measuring- at 290 mu the .amount of uric 
acid formed. Nucleoside phosphorylase is then added. 
Thus, any inosine present is also converted eventually to 
uric acid. Inosine concentrations may be calculated then 
from the additional increase of optical density at 290 mu. 
Inosine and/or hypoxanthine concentrations were 
calculated per 2 ml of Total and per 1 ml of Medium. The 
difference between the two equaled the cell concentration. 
The results of samples incubated in 12.5 wnoles of 
inosine/ml are shown in Figure 15*. The fact that inosine 
upon entering the cell was quickly converted to hypoxan-
thine and ribose-1-P by the nucleoside phosphorylase of 
the cell was noted with preparations incubated in media 
22 
containing inosine. • Approximately half of this hypo-
xanthine returned tp the medium. Therefore, inhibitory 
effects, if any, would be due mainly to hypoxanthine 
rather than inosine. Possible significant inhibitory con-
centrations of inosine ,.,ere found at the end of 3 hours 
of incubation only when inosine concentrations of 12.5 
umoles/ml, or higher, were added to the medimn. With all 
cell preparations hypoxanthine ultimately accumulated 
within the depleted erythrocytes at concentration equal 
to, or greater than, the inosine or hypoxanthine original-
ly added to the medium. 
*See Figure 15, p. 37. 
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One similar experiment we,s done with freshly drawn 
blood, Hct. - 43%, \'Ti th 5 urnoles of inosine/ml added. 
The same rapid equilibration of the hypoxanthine and the 
inosine was found to occur between cells and plasma. 
Phosphorolysis of the inosine by the cell, though, was 
slightly slower. 
Enolase Concentration in the Erythrocyte 
Since hy~Joxanthine concentrations l.Yere found to 
accumulate within the erythrocyte equivalent to the amount 
of inosine added to a cell preparation, the next step taken 
was to see if hypoxanthine, at concentrations observed to 
inhibit blood enolase in vitro, could account for an inhi-
bition of enolase "ttithin the intact RBC. It, therefore, 
was necessary to 1~ow first the activity of enolase in 
blood. 
Because sugar phosphates, including 2-PGA, do not 
readily enter erythrocytes22 , 47, intact cells could not be 
used in the routine enolase assay system. Earlier studies 
on enzymes of erythrocytes had been done by Lohr21 with 
hemolysates of fresh, washed RBC's. Consequently, his 
method of hemolysate peparation was used to study enolase 
activity in the RBC. Depleted cells were vre.shed three 
times with 0.15 !v1 NaCl, and the \'lhite blood cells removed. 
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The cells were suspend-ed in P04-Ringer solution, pH 7.4, 
to give a Hct. of 30%. Hemolysates \'rere prepared by add-
ing 1 ml of suspenced RBC's to 2 ml 0.025 M Tris, pH 7.4, 
containins 0.2 ml of saturated digitonin solution, and 
kept at 3°C for 60 minutes. The stroma was then centri-
fuged down and the hemolysate assayed immediately. 
The hemolysates were assayed for enolase first by 
18 the method Kun used on tissue homogenates • This consist-
ed of incubating samples of the hernolysate with 0.003 M 
2-PGA, 0.0015 M I~gC12 , 0.05 M Tris, pH 7.4, and 0.3% Gly-
cine; precipitating the protein with HCl04 ; and, measuring 
the increase of OD of the filtrates due to PEP at 240 mu. 
However, this method was found to give inconsistent results. 
Instead, it was found that the high sensitivity of 
the Zeiss spectrophotometer made it possible to measure 
the reaction directly, as had been done in the routine 
assay. The high absorption of the hemoglobin )resent in 
the hemolysates could be blanked out. Protein determina-
tions23 were done on each of the hernolysate preparations 
and cell suspensions in order to compare specific activi-
ties of different samples. 
The hemolysa te lJrepara tions shovred a linear rela-
tionship between enolase activity and protein concentre.-
tion, as would be expected for the enzyme. The effect of 
hypoxanthine on eJIOlase·in the hemolysate was measured 
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spectrophotometrically. The results are shown in Figure 
16*. Inhibition did appear to occur within the same con-
centration range as with rabbit muscle, yeast, and par-
tially purified RBC enolase. No initial stimulation of 
activity, however, was noted. Rather, a more gradual in-
hibition was measured. This might have been accounted for 
by impurities within the preparation. 
Calculation of the specific activities** showed 
that hemolysates prepared from both depleted and fresh 
cells had similar activities. Hemolysates prepared with 
digitonin and by the freeze-thaw technique also gave the 
same results. Maximum velocities were determined from 
Lineweaver-Burk plots at 25° and 37°C, and specific acti-
vities were subsequently calculated. Specific activities 
for our blood samples were found to be much lovTer than 
those reported by either Lohr on blood hemolysate enolasel 
or by Kun for tissue homogenate enolase1C.o~t-*. 
The reason for our low activity rates is unknown. 
Kun, whose results for enolase in various rat tissues were, 
in general, in the order Lohr reports for human blood, 
used an assay system which began with 3-PGA, rather than 
2-PGA, as the substrate, plus the necessary enzymes and 
cofactors. The increase of PEP at 37°C was read by meas-
*See Figure 16, p. 41. 
**See Table 7, pp. 42 & 43. 
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Table 7. Enolase Specific Activities. 
Source 
l. crystalline brewer's 
yeast (32) 
2. partially purified 
brewer 1 s yeast 
3. crystalline rabbit m 
muscle 
4. 
Assay Conditions 
. -3 2.4 x 10_3 M DL+~-PGA 1.0 X 10_5 M Mg 
1.0 x 10 M EDTA (or Tris) 
u = 0.05 pH= 7.4 
own assa~~ (l) 3.o x 1o: M 2-~~A 
2.5 X 10 M Mg 
0.03 ml 1~% Glycine 
5.0 x 10- M Tris, pH 7.4 
(2) same as i~) except: 
6.0 X lO,.~,M 2-~~A 
· 1.5 X 10 M Mg 
own assay (2) 
blood hemolysates from: 
~al depleted cells at 25~C . b II II II 37 C c fresh cells at 25gc d II II II 37 C 
own assay (l) except 
o.3 umoles 2-PGAfml 
5. partially purified blood own assay (2) 
(cont 'd.) 
-, 
SpEfcific -~ 
Activity 
(Q!)/gtg/min) 
120.00 
144.40 (8/61) 
49.60 (3/62) 
16.00 
.00272 
.00345 
.00335 
.00588 
.0097 
.f:=' 
1'\) 
~ 
Source 
6. blood hemolysate 
7. tissue homogenate 
from rat spleen 
Assay Conditions 
} 
Speclfic 
Activity 
(QD/mg/min) 
Lohr's as~ay (21): .1106 
2.0 :x 10:~ M ADP 
7.5 x 10 M KCl 
7.5 x 10:~ M MgS04 
1.5 x 10_6 M DPNH 
5.0 x 10 6 g/ml pyruvate kinase 5.0 x 10:7 g/ml lactic dehydrogenase 6.0 X 10 M 2-PGA 
5.0 x 10-2 M Trisethanol~mine up to 2 ml 
pH = 7.5 temp. = 25 C 
Kun's assay
3
(18): .0918 
25.0 x 10:3 M 3-PGA 10.0 x 10 M MgS04 
Tris buffer, pH 6.8 
o.9% KCl up to 1.5 ml 
0 temp. = 37 C 
..(::::" 
LA> 
uring acid-labile phosphorus. He did not mention the pos-
sible presence of pyruvate ki11ase in his tissue homogenates 
or how he excluded its effect on the enolase assay. 
Lohr's assay was carried out at 25°C with ADP, 
DPNH, pyruvate kinase, and lactic dehydrogenase added. 
The decrease in DPNH was measured spectrophotometrically 
at 366 mu as a criterion of enolase actj_vity. The pyru-
vate kinase and lactic dehydrogenase remove the PEP as 
fast as it is formed by enolase causing perhaps the eno-
lase activity to appear higher. The possibility that 
Lonr's assay, for some reason, would give higher results 
for enolase activity than the routine assay used by us was 
checked. Yeast enolase was assayed by both our method and 
that of Lohr's. \ihen corrected for the difference in ex-
tinction coefficients of the two products, PEP and DPN, 
measured at 240 mu and 366 mu, respectively, no signifi-
cant difference was noted in the enolase activity. 
Tl1e impurity of the hemolysate preparations pre-
sents the problem of a possible removal of PEP by pyru-
vate kinase and lactic dehydrogenase. Since the routine 
assay measured PEP formation, the action of these two 
enzj~es would tend to give low results. However, according 
to Denstedt8 and others, lactic dehydrogenase is not active 
in hemolysates. Moreover, only negligible amounts of ADP, 
a necessary cofactor for pyruvate kinase activity, are 
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added to the assay medium when adding the sam~le. This 
amount would be in1mediately metabolized to ATP causing a 
decrease in the initial velocity only. Furthermo~ hemol-
ysates treated with Norit to remove the nucleotides had 
essentially the same enolase activity as untreated samples. 
Therefore, evidence points towards the fact that pyruvate 
kinase was not interfering with the routine enolase assay. 
The enols.se activity in one ml of RBC' s, Hct. = 50% 
was calculated based on the results of Lohr, i.e. 250 mg 
protein/ml cells x 0.11 OD/mg protein/min. = 27.75 OD/ml 
cells/min •• Y~ast enolase at a concentration which had 
enzymatic activity of the order of 27.75 OD/min. lias then 
assayed with hyl::;o:x:anthine added to the medium. These 
studies also showed complete in:libi t.ion of enolase at 
these hi;h enzyme concentrations b~ 0.75 umoles hypoxan-
tl."line/ml. Thus, hypoxanthine at low concentrations might 
be capable of inhibiting enolase within the intact erythro-
cyte. 
Comoarison of the Effect oi' Hy-ooxanthine and F-
on the Metabolism of Intact Erythrocytes 
Having observed that inosine and hypoxanthine at 
low concentrations appeared to inhibit completely amounts 
of e:c.ola::;e equivalent 'uo the concentration in erythrocyte~ 
and that inosine a:'ld/or hypoxanthine wi.1en added to erythro-
" 
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cyte preparations enter the cell in concentrations at 
least equal to, if not greater than·, the concentration in 
the mediuru., it was of interest to know whether addition of 
these compounds to erythrocyte preparations did in fact 
inhibit glycolysis at the enolase level. For this pur-
pose, the effect of inosine and hTpoxanthine on glucose 
utilization, lactic acid formation, and P~ 2 transport was 
compared to the effect of~~ which has been well extab-
8 41 42,45 lished as an enolase inhibitor ' ' • 
Glucose utilization normally exceeds 0.5 umoles of 
glucose/ml/hour at 37°c41 , yielding two mole-equivalents of 
lactic acid54. 0.010. M NaF inhibits glucose utilization42 
and lactate production27 substantially. Also, in normal 
glycolyzing RBC's, Pf2 is slowly taken up by the cell and 
incorporated into its phosphate esters. Cells incubated 
in the presence of F- not only take up Pf2 more slowly 
than normal but the specific activity of the P~2 in the 
plasma decreases faster than normal. This is attributed 
to ester phosphate breakdown within the cell, causing a 
dilution of the total Pi of the plasma12 , 41 , 47. 
The following describes the method and the results 
of one series of experiments*. 4 samples of 25 ml fresh 
*See Figures 17 - 21, pp. 47 & 48. ~.,.concentration in 
blood equals approximately 0.0015 M • Therefore, 0.010 
M NaF equals approximately ten times 67% inhibitory con-
centrations. 0.005 M·hypoxanthine or inosine also equals 
approximately ten times its apparent 67% inhibitory con-
centration. 
4 
3 
2 
10 40 70 100 130 160 190 
Minute• 
FIGURE 171 GWCOSB U'l'ILIZATIOR BY RBC's. 
• 
• ..... 
i 
9 
7 
5 
3 
1 
./ 
+ Hypo. ···'· ..... 
A •••• ••" 
-.... .., .... 
. --·· __,., 
... .., 
... .... ..... 
.... . ·. ,.. ........ 
... ·- .... ..... Control 
• 
..... ··· ..... .., 
. . .,.· .... -
.. .. -.::,.. ..... 
. ... ~ + HaF t=".,:;, . 
• 
• 
10 40 70 100 
Minute• 
PIGURB l81 LAC'1'lft POIUIATIO. BY IlK' •· 
• Control, x ____ • • ~.-.a.r~Jixanthine 
4 •.. • + t.OlO M llaP. 
47 
I 
.., 
r-i 
Ill 
r-i 
~ 
..... 
"' ~ 0 
rt 
• 
• r-i § 
10 
8 
6 
4 
2 
, 
;· 
X 
x/+ NaF 
~~~~~-·····-··L-~?!~ 
..------ A --. ----.
contro 
4.0 
3.5 11 
.., 
e 
to 
.., 3. 0 
rl 
flo. 
t~\A \x \ \ \ 
\ . 
\ \. , 
\ \.~ + NaF \\ .···· .. "'A---• 
\ ·· .... 
\ '+. Hypo. 
\ ·· ... 
', ·····--·- .... _e. 
'· 1 ', Contro ............ 
rl 
~ 
e a. 2. 5 
() 
2.0 
0 
100 150 200 1 · 5 0 50 100 150 200 0 50 
Minutes 
P'IGORE 19: 
Minutes 
FI<;;URE 20: 
.., 
e 
Ul 
10 
rl 
flo. 
flo. 
Ul 
Qj 
..... 
0 
~ 
"-... 
a 
() 
1 3 
11 
9 
7 
5 
I 'IC , 
"\ 
~ 
\\ -~\\ \' 
.,. \ 
~ 
~, 
\ ' ,col\trol 1\, ' ;~'·. , ....... A '· • ._ Cl -.... .... _. 
''··- .A. 
.......... -.....rd. 
+ Hypo 
+ NaF '""'· 
3 o1 so 166 i~o 2do 
Mjnutes 
FIGURE 21: 
PI 2 TRANSPORT BY ERYTROCYTES 
...(::-
():) 
49 
heparinized whole blood were added to 4 flasks containing 
5 ml each of isotonic solutions previously equilibrated at 
in air. 
0 The flasks were slowly s11aken for 3 hours at 37 C 
1 and 3 ml aliquots were taken from each flask at 
10, 40,_ 70, 130, and 190 minutes. Hematocrits of all four 
flasks remained between 44% and 43% during the incubation 
time. 
1 N HCl04 was added to the 1 ml samples to denature 
the protein. _They were then centrifuged. 1 ml of the 
clear filtrate was neutralized with 1 M KOH.. 1 ml 1M 
Tris, pH 7.4 was also added. The final dilution was 10 ml. 
These supernates were designated as Total. l ml of plasma 
was removed from the centrifuged 3 ml samples and treated 
as above. These supernates were designated as Plasma. 
Glucose utilization was determined by measuring glu-
cose concentrations of the Total samples with the Worthing-
ton glucostat kits. Lactic acid formation was followed by 
measuring lactic acid concentrations in the Total samples 
spectrophotometrically with the enzymatic assay of Wight 
and Burk55. Pi2 transport was based on total phosphate 
and p~2 specific activity determinations41 of both Total 
and Plasma samples. 
Figures 17 - 21* illustrate glucose utilization, 
lactic acid formation, and P!2 transport by the four cell 
*See Figures 17 - 21, pp. 47 & 48. 
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preparations. No indica'"tion of any inhibition of' the 
three processes was found to occur in cells treated with 
hypoxanthine, even though F- treated cells definitely were 
inhibited. 
Although the above data were collected from only 
one series of experiments, the results did imply that enol-
ase is not iru~ibited by hypoxanthine in the intact, meta-
bolically active erythrocyte. Since this conclusion was 
borne out by information from later experiments reported 
in the following section, repetition of the above work did 
not seem necessary. 
Effect of Hyuoxanthine on Enolase 
under Various Assay Conditions 
In vitro studies, as reported in the preceding 
pages, gave no definite information of the mechanism of the 
inhibition of enolase by purine and pyrimidine derivatives. 
In the literature only two papers were found which eight 
have had some bearing on our problem. An abstractS on the 
effect of nucleic acids on the enzymic function of proteins 
reported that recrystallized muscle enole.se under.soes 1 a 
reversible inhibition on its union ,.,i th nucleic acids. 
The organic base derivatives used in this study were nucle-
ic acid components. It was possible that the two types of 
inhibition were, thus, related to one another, although no 
" 
evidence for reversi bi'li ty of the inosine inhibition rlas 
ever obtained. 
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A paper on the urea denaturation of enolase by Malm-
strom34 shmved a denaturation inhibition curve similar in 
shape to that of the inosine inhibition phenomenon, al-
though no initial stimulating effect was noted and the con-
centration of urea necessary for inhibition was five to 
ten times greater than that necessary with inosine. Per-
haps inosine might also inhibit enola,se activity by a de-
naturation mechanism. This was further suggested by the 
fact that as the hypoxanthine concentration in an assay 
medium was increased, the final optical density at which 
the reaction stopped decreased. This would indicate that 
the reaction was not reaching its normal equilibrium. A 
progressive denaturation of the enzyme by hypoxanthine 
coUld cause such an effect. However, incubation of the 
enzyme with hypoxanthine prior to the addition of the sub-
strate caused no decrease in the initial velocity of the 
enzyme, as would be expected if denaturation were occur-
ring. 
The puzzlins effect of nucleosides on the kinetics 
of the enolase reaction, the abnormal shape of the inhibi-
tion curves, and the lack of any indication that inhibition 
took place in intact erythrocytes, thus required a reexam-
ination of the original observations. 
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A distinct possibility was that the observed de-
crease in enolase activity did not represent inhibition 
at all, but was related rather to the method of assay. 
Therefore, different methods of assaying enolase activity 
were employed to see if the hypoxanthine inhibition phe-
nomenon would still be observed. The .effect of hypoxan-
thine on Lohr's assay was first tested. As mentioned 
earlier*, the assay includes the enzymatic steps seen in 
Figure 22. Enzyme activity was determined by measuring 
Figure 22. Reaction Sequence of Lohr's Assay for 
Enolase Activity. 
H20 ADP ATP 
2-PGA < "'• PEP > <!~ pyruvate 
DPNH DPN 
.,.,, 1:., lactic acid 
enolase pyruvate lactic 
kinase dehydrogenase 
spectrophotometrically at 366 mu the rate of change of 
DPNH to DPN rather than PEP formation at 240 mu as in the 
routine assay. No inhibition of enzyme activity was ob-
served with this assay method even in the presence of 
hypoxanthine as high as 4.0 umoles/ml, i.e. a concentra-
tion approximately six times greater than that used to 
give 100% iruLibition with the routine assay method. 
A second series of enolase assays was also run in 
the presence of hypoxanthine in concentrations of 0.0 -
1.0 umoles/ml using the conditions of the routine assay 
but measuring PEP formation this time with a modification 
*See p. 44. 
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of_Lohmann and Myerhoff's iodine-labile phosphorus meth-
20 
od. • Each sample was incubated at room temperature and 
the reaction stopped at the end of five minutes by the 
addition of 1 ml of 15% HC104. Iodine-labile phosphorus 
determinations were then done on each of the acid fil-
trates. No inhibition of enolase activity by hypoxan-
thine was apparent when PEP formation was determined in 
this manner. It therefore seemed highly probable that 
the original observations indicating enolase inhibition 
were an artifact related to the method of assay. 
Absorption Spectra 
The question, then was: why do purine and pyrim-
idine derivatives appear to inhibit enolase activity when 
measured spectrophotometrically at 240 mu. There are 
various possibilities. (1) These bases all have high ab-
sorption maxima in the neighborhood of 240 mu*. The ab-
sorption by purine and pyrimidine derivatives does not 
follow Beer's law at concentrations as high as 1.0 umoles/ 
m117 • We found this to be true above concentrations of 
0.35 umoles hypoxanthine/ml**· However, this lacl~ of 
linearity should not interfere vri th a measurement of rate 
of change of OD. Moreover, the OD due to hypoxanthine 
*Bee Table 4, p. 23. 
**See Figure 23, p. 54. 
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was blanked out before the enzyme was added. 
(2) The instrument itself could be less sensitive 
at high amplifications and with a wide slit, both of 
which are necessary in order to measure enolase in the 
presence of hypoxanthine concentrations approaching 1.0 
umoles/ml. This would result in an apparent decrease of 
any OD change. However, identical standard curves were 
obtained for hypoxanthine at high, medium, and low slit 
openings which necessitated low, mediwn, and high ampli-
fication. 
(3) There is always the chance that stray light 
within the spectrophotometer is interfering with the meas-
urements of light absorption at particular wavelengths. 
The spectrophotometer is a combination of a monochromator 
and a photometer. The beam of white light, from which the 
monochromator selects light of a specific wavelength, also 
may scatter off the light source, mirrors, prisms, etc •• 
This allows some light to reach the exit slit which is 
outside. the wavelength band of the monochromator. Some 
of this light vlill be of wavelengths which are not ab-
sorbed by the solution in the cuvette, and hence will 
reach the photometer in addition to the light of the par-
ticular wavelength selected by the monochromator. There-
fore, when measuring absolute OD's of increasingly great-
er concentrations of a solution with a high extinction 
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coefficient, stray light may eventually represent a large 
percentage of the light which reaches the photometer. 
However, if relatively small continuous changes in OD 
were being measured after the high absorption of the orig-
inal solution had been zeroed out, as was done with the 
routine assay, the effect of stray light should not in-
terfere. 
(4) An interaction could be occurring between 
hypoxanthine and PEP. This prompted the following exper-
iment. Four cuvettes were set up in pairs so that light 
from the monochromator passed through two at a time as · 
shown in Figure 24. H2o, inosine and/or PEP were placed 
Figure 24. Outline of the Study of the Absorption 
Spectra of PEP, Inosine, and PEP Inosine. 
Cuvette: 
' __ '/\{, 
-~ .. 
light 
Experiment: 
Blank: 
Sample: 
*Ino. • Inosine. 
0004N 
PEP 
DO 
0005 ! .ooD4t1 
Ino f'EP 
in the cuvettes alone or mixed in the combinations illus-
trated. The spectrophotometer was zeroed with the top 
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pair of cuvettes (the blanks) at each change of wave-
length between 228 mu and 300 mu, and the OD of the bot-
tom pair was read against the blank. Therefore, in 
Exp. A the spectrum for PEP was obtained corrected against 
H20. Exp. B took into consideration the OD due to ino-
sine at a concentration which had been found to cause a 
50% inhibition of enolase activity. No contact between 
inosine and PEP existed in this case. Therefore, there 
was no possibility of binding. The PEP spectrum was cor-
rected against inosine. Exp. C is similar to Exp. B 
except that the inosine and PEP are mixed and, therefore, 
binding could take place between them. Exp. D is the 
same as Exp. C with only avariation on the blank. 
As Figure 25* shows, spectra obtained for Exper-
ments B, C, and D are all the same and differ from Exp. A 
in that the absorption of light by the PEP is decreased, 
i.e. the PEP spectrum is shifted towards a shorter wave-
length. Curiously enough, the largest decrease is in the 
240 mu area of the spectrum, the wavelength at which PEP 
concentration is measured spectrophotometrically. More-
over, this decrease would account for both the per cent 
decrease in rate of change of OD in the enolase assay as 
the hypoxanthine concentration wss increased and the de-
crease in the final OD of the reaction as observed in our 
*See Figure 25, p. 58. 
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earlier studies. Since Exp. B has the identical change 
in the PEP spectrum as does Exp. C, binding between hypo-
xanthine and PEP does not appear to be the cause of the 
decrease in PEP absorption. The effect is apparently due 
to some optical property of the system which is at pre-
sent unexplained. 
Further careful and detailed spectrophotometric 
studies of the optical properties of both hypoxanthine 
(and other purine and pyrimidine derivatives) and PEP 
will be necessary before this question can be resolved. 
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SlJM1.1iARY 
1. In vitro enolase activity determined by measuring 
PEP formation spectrophotometrically at 240 mu 
appeared to be inhibited by inosine at relatively 
low concentrations (0.25- 0.75 umoles/ml). Enol-
ase isolated from various sources, i.e. rabbit 
muscle, brewer's yeast, and blood, all were effect-
ed identically. 
2. Hypoxanthine, the base moiety of the nucleoside, 
,.ras found to cause the apparent iP ...... 'li.bi tion. In 
addition, other purine and pyrimidine derivatives 
inhibited to varying degrees; however, no correla-
tion between structure and degree of inhibition was 
evident. 
3. Kinetic measurements gave no definite information on 
the mechanism of the inhibition. LineHeaver-Burk 
plots gave lines with no common intersection. The 
inhibition ,.,as une.ffected by changing the Mg ..... con-
centration, so it could not be attributed to com-
plexing of the metal ion in a manner similar to F-. 
Moreover, all the purine and pyrimidine derivatives 
had an unexplained initial stimulating effect on 
" 
enolase activity. Therefore, this inhibition phe-
nomenon appeared to be abnormal. 
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4. In experiments to assess what role this inhibitory 
effect might play in erythrocyte metabolism, inosine 
was found to penetrate the human RBC rapidly, where 
it is immediately metabolized to hypoxanthine. 
Therefore, hypoxanthine, not inosine, v-rould accumu-
late in the cell at inhibitory concentrations. How-
ever, a comparison of the effects of hypoxanthine and 
F-, a known enolase inhibitor, on glucose utilization, 
lactate formation, and p~2 transport gave no evidence 
for any inhibition of glycolysis at the enolase level 
with hypoxanthine. 
5. The negative results from the intact erythrocyte 
studies, along with the puzzlins effect of inosine on 
the l\.inetics of the enolase reG.ction and the abnormal 
in::1ibi tion curve, led to a re.exaw:i.nation of the orig-
inal observations. Further investigation, using 
enolase assays not dependent on a spectrophotometric 
measurement at 240 mu showed conclusively that hypo-
xanthine actually does not inhibit enolase. The 
initial observation of a decrease in enolase activity 
seemed, rather to be an artifact of the original 
assay used. 
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6. Possible explanations 6f the observed decrease in the 
OD of PEP were: (1) a lack in conformity to Beer's 
law by puri~le o.nd pyrimidine derivatives; ( 2) a de-
crease in sensitivity of the spe~trophotometer at 
high amplification and wide slit openings; and (3) 
stray light within the spectrophotometer. However, 
the assay media containing hypoxanthine vrere zeroed 
out prior to the addition of enolase and rates of 
change in optical density, rather than absolute op-
tical densities, were being measured. Thus, none of 
these reasons appear to explain the observed decrease 
in the OD of PEP. An interaction between the base 
and PEP causins a possible change in the spectrmn of 
PEP vras also shown not to occur. 
7. Hmvever, purine and pyrimidine derivatives do absorb 
strongly at 240 mu, approximately ten times that by 
PEP. Studies of the absorption spectra of PEP and 
inosine, individually ru1d in various combinations, 
showed that the high optical densities of these bases 
somehow cancel the OD of PEP measured spectrophoto-
metrically, particularly in the area of 240 mu. 
8. Further study of the optical properties of the two 
compounds vfill be necessary to resolve the problem. 
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ABSTRACT 
In studies on the formation of 2,3-diphosphogly-
cerate (2,3-DPG) from inosine by erythrocyte preparations 
it was observed that the inosine interfered with the 
enzymatic assay for 2,3-DPG. Phosphoglyceromutase, for 
which 2, 3-DPG is a coenzyme, and enolase rrere used in a 
coupled assay. The inosine appeared to interfere by 
inhibiting the enolase. 
The significance of such an inhibition of enolase 
by inosine would be considerable. Nucleosides, rather 
than glucose, have been used as a sugar source for eryth-
rocyte preparations because of the ability of nucleosides 
to prolong the viability of stored erythrocytes. It has 
been demonstrated that addition of in~sine and adenosine 
to blood which has been depleted of 2,3-DPG by storage 
or prolonged incubation leads to rapid restoration of the 
2,3-DPG level. This rather specific effect has been 
attributed to the fact that nucleosides bring in Pi in 
addition to the pentose by the action of a nucleosidE 
phosphorylase at the cell surface. It has been further 
suggested that tte availability of pentoses rather than 
glucose as a carbon source might reduce the requirement 
for ATP, since pentoses partially sidestep the initial 
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ATP requiring step in glycolysis. The additional Pi made 
available to the cell might t~en be stored as 2,3-DPG in 
circulating human erythrocytes. Now, the fact that the 
nucleosides may produce a metabolic block at tl;.e enclase 
level ~ust be also considered in relation to its effect 
on increc:"sing 2,3-DPG synthesis in t:'ne hun:an R:SC. 
Inosine and vari.us 1ther purine ~nd pyrimidine de-
rivatives are n0rmally found in the R3C, but in low con-
centrations. On the other hand, the adenine derivatives 
do approach in:~ibitory concentrations. Therefore, nucleo-
sides might also :participate ln c.. control T!echanism for 
erythrocyte glycolysis. 
The purpose of tLis i~vestlsation was to study the 
effect of inJsine, and other purine and ]yriillidine deriv-
atives, on enolase activity. 
The initial series of experiments wss designed to 
exaffiine in detail the effect of in~sina on e~olase activ-
ity. The assay used in these studies depended un the 
reaction: 
2-PGA* 
enolase 
The rate of form&tlon of phosphoenolpyruvate (PEP) was 
followed spactro)hotometrically at 240 mu. 
The activity of both crystallized r~bLit muscle 
and pc.Lrtially .:.mrifie d yeB st elL·Lo se s .!) _)e8rc d tc 1Je inLi-
12-phosphoglycerate. 
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bited by in~sine ctt reLatively l·~W concentratior:s (0.25-
0.75 umoles/ml). Similar results were obtained with psr-
ti&lly pt:.rified blo .. :d enolase, in ',-<hict \\3 c·:e~~e _princi-
pally interested. 
Compa.rative studies were t; e~~ dc.·ne Ni tr. other 
purine and pyrL;,~dine deri va ti ve s. All inti bi ted enol?· se 
and degree of lntibition was evldent. ~e free base, 
hyp0xantr~ine, w-ss lnLi bi tory ·,.;-LJ.le ribose alone was nut, 
indicating that it w2.s the base 11oiety ;,((_ich w~".s C:&.1Jsing 
the inh:L bi tiJn. 
Attempts ·r:ere made tc c.bti:iin infcrmatlon c.:n the 
mechanism of inhibition from kinetic studies. Eowever 
Lineweaver-Burk ~lots of substrate concentrati.n - reac-
tion velocity data ge:.ve ambigucus rc:3vlts. The inhi bi tlon 
"\'las alsc t:.nsffe cted ·oy changing the I:.fgH ccr.cent!';c 'tl.,;n, so 
lt could not be attributed to com)lexing 0f tbs net2l ion 
in a manner similPr to fluoride, a ~nwwn enulase inhibitor. 
~oreover, all tte purine and pyrimidine deriv2tives Lad 
an unex~)la ine d lni tlal stimuli' ti ve c ffe ct oL er~:; lase a c-
ti vi ty. TLere fore, t". e kinetl cs d lnL;_ bit'_ .:Hl were ie-
ci ded_ly C:t·bnor·rDa.l. 
Ex_perimen ts with eryt:Crocyte _;_Jrc; .. :s rs.ti..;r ... s incubated 
with in••sine (2.5- 12.5 umoles/ml) were ae;;ain U3ed to 
study what ef?ect, if any, inosine might h2ve un R1C 
" 
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metabolism. A praraquislte fsr inosine tG be an effec-
tive metabolic lnhlbltur would be that it enter the cell. 
EnzymB.t i. c assay for inosine and hypoxan tr~ine of sa:nple s 
taken from tt~e incubatLn~. iJiedium at tiJ;ed intervals 
showed that in0sine did rapidly )enetrate the cell. Eer~ 
it was lrmr;_edia tely metabolized to hyyJxantbine, 2,ppr<Jxi-
mately half Jf which passed bac:{ into tr~e ccediurr.. Con-
sequently, it was hypoxanthine, not inosine, whose possi-
ble inhibitory ef ects in the cell were tc be considered. 
HoHevar, a com:Qarison _f the effects of equivalent inhibi ... 
tory concentrations of hypuxanthine and fluoride on glu-
cose utiliz2tion, lactate formation, and P~2 transport 
showed no simil2rlty. Hypox~nthine gave no evidence of 
any inhibition of glycolysis at the enolase level within 
the RBC. 
In separete experiments the enolase concentratiJn 
in erytLrocytes was measured, using the routine assay 
method. The rssults disagreed with t1ose in tLe litera-
ture. Revort~eless, levels we~e such that red cell enol-
ase would be 100~ inLibited at the hvnoxsnthine concen-
, u ~ 
trations employed. 
The negative results frolli the metabGllc studies, 
alung with t~e puzzling abnormal kinetics of inhibition 
produced by inJsine on the enolase reaction led to a 
reexaminati8n of the original obsarvations. The original 
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inl:..i bi tiun experiments ~{ere repeated usLng en ..;lase assays 
which did not de::_;end on a spectrophotometric me8surement 
at 240 mu. These included: (1) an assay wt.ich deter-
mined enolase activity by measurlng s)ectrophotometrically 
at 366 mu the disappearance of DPNH in the reaction se-
H20 ADF .ATP 
2-PGA ~~.a. PEP ~ ....... pyruvate 
enolase pyruvate 
kinase 
D?li1:E DPN 
~-~'==~~~-~--lactic acid 
l&ctic 
dehydrogenase 
and, (2) determination of the PEP formed in the routine 
assay by a modification of Lohmann and Myerhoff' s i:.Jdine-
labile phosphorus method. The results showed conclusive-
l'y that inosine actually does not inhibit enolase. The 
initial observation of a decrease in enolase activity in 
the presence of inosine seemed, rather, to te an artifact 
of the original assay used. 
All purine and pyrimidine derivatives have high 
absor)ti~n maxima near 240 mu, with extinction coeffi-
cients approximately ten times that of PEP. The higL 
background absorption caused by these bases necessitated 
using the s}ectrophoton:eter at wide slit openiness and/or 
high amplification. This introduces several possible 
sources of error. (1) Decrease in sensitivity of tha 
photomultiplier at low light intensities. However, iden-
tical standard curves were obtained at all amplification 
levels. (2) Purine and pyrimidine derivatives do not 
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follow Beer's Law at high concentrations. But this would 
not interfere because the base w~s also used as a blank. 
(3) The use of tts base as a blank also argued against 
errors as a result of stray light leakin~ through the 
monochromator. (4) Interaction between PEP and the base 
causing a reduction in absorption by PEP. This was elim-
inated by dJuble cuvette experiments in which t1e light 
was passed through solutions of PEP and inosine in sepa-
rate cuvettes, one behind the other. This cor:,bination 
gave a spectrum identical to that of a mixture of the two 
solutions in the same cuvette. However, both spectra 
showed substantially less absorption than a solution of 
PEP alone, particularly at wavelengths near 240 mu. 
Therefor% the nature of the interference of inosine 
in the assay is stil not clear. Further study of the 
optical properties of the two compounds will be neces3ary 
to resolve the problem. 
